New eczema drug shows promise in Mid-Stage trial

NCT ID NCT07230860

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests an experimental drug called JNJ-95597528 in 180 adults with moderate to severe atopic dermatitis (eczema). Participants will receive either the drug or a placebo to see if it improves skin symptoms by at least 75% after 12 weeks. The goal is to control the disease, not cure it, and ongoing treatment may be needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATITIS ATOPIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Allergy Research Canada Inc.

    Niagara Falls, Ontario, L2H 1H5, Canada

  • Arlington Dermatology

    Rolling Meadows, Illinois, 60008, United States

  • CCA Medical Research Corporation

    Ajax, Ontario, L1S7K8, Canada

  • CIPREC

    Buenos Aires, C1061AAS, Argentina

  • Center for Clinical Studies

    Houston, Texas, 77004, United States

  • Centro Respiratorio Infantil

    Rosario, 2000, Argentina

  • Centro de Investigaciones Clinicas CIC IESR

    Rosario, 2000, Argentina

  • Centro de Investigaciones Medicas Tucuman

    San Miguel de Tucumán, T4000AXL, Argentina

  • Ceti - Centro de Estudos Em Terapias Inovadoras

    Curitiba, 80030 110, Brazil

  • Chang Gung Memorial Hospital

    Kaohsiung City, 833, Taiwan

  • China Japan Friendship Hospital

    Beijing, 100029, China

  • Chung Shan Medical University Hospital

    Taichung, 40201, Taiwan

  • Clinical Research Philadelphia

    Philadelphia, Pennsylvania, 19114, United States

  • DOM Reumatologia

    Buenos Aires, C1111, Argentina

  • Dawes Fretzin Clinical Research Group

    Indianapolis, Indiana, 46250, United States

  • DermEdge Research

    Mississauga, Ontario, L4Y 4C5, Canada

  • Derma Internacional S A

    Buenos Aires, C1426, Argentina

  • Dermatology Research Institute Inc

    Calgary, Alberta, T2J 7E1, Canada

  • Dr Wei Jing Loo Medicine Professional Corporation

    London, Ontario, N6H 5L5, Canada

  • Driven Research LLC

    Miami, Florida, 33126, United States

  • First OC Dermatology

    Fountain Valley, California, 92708, United States

  • Fundacao do ABC Centro Universitario FMABC

    Santo André, 09060 870, Brazil

  • Henry Ford Health System

    Detroit, Michigan, 48202, United States

  • Hosp. of Chengde Medical University

    Chengde, 067030, China

  • Hospital De Clinicas De Porto Alegre

    Porto Alegre, 90035 903, Brazil

  • INAER - Investigacion en Alergias y Enfermedades Respiratorias

    Buenos Aires, C1425BEN, Argentina

  • ISA - Interdisciplinary Study Association GmbH

    Berlin, 10789, Germany

  • Instituto Brasil de Pesquisa Clinica

    Rio de Janeiro, 20241 180, Brazil

  • Instituto Medico De Alta Complejidad (IMAC)

    Buenos Aires, B1643CRO, Argentina

  • Instituto de Investigaciones Clinicas Cordoba

    Córdoba, X5000AAW, Argentina

  • Jitaikai Tachikawa dermatology clinic

    Tachikawa, 190 0023, Japan

  • Kaohsiung Veterans General Hospital

    Kaohsiung City, 813, Taiwan

  • Kindai University Hospital

    Sakai, 590 0197, Japan

  • Klinikum rechts der Isar an der Technischen Universitat Munchen

    München, 80802, Germany

  • Kume Clinic

    Nishiku, 593-8324, Japan

  • Linkou Chang Gung Memorial Hospital

    Taoyuan, 333, Taiwan

  • Mautalen Salud e Investigacion

    CABA, C1128AAF, Argentina

  • Miyata Dermatology Clinic

    Matsudo, 271-0092, Japan

  • National Taiwan University Hospital

    Taipei, 10048, Taiwan

  • Nomura Dermatology Clinic

    Yokohama, 221 0825, Japan

  • Oregon Dermatology and Research Center

    Portland, Oregon, 97210, United States

  • PSEG trials Centro de Pesquisa Clinica S A

    São Paulo, 04038 002, Brazil

  • Pesquisare Saude

    Santo André, 09080-110, Brazil

  • Progressive Clinical Research

    San Antonio, Texas, 78213, United States

  • Red River Research Partners LLC

    Fargo, North Dakota, 58103, United States

  • SOLUMED Centrum Medyczne

    Poznan, 60 529, Poland

  • Sanmenxia Central Hospital

    Sanmenxia, 472000, China

  • SimcoDerm Medical and Surgical Dermatology Centre

    Barrie, Ontario, L4M 7G1, Canada

  • Southern California Dermatology

    Santa Ana, California, 92701, United States

  • Studienzentrum an der Hase GbR

    Bramsche, 49565, Germany

  • Taipei Medical University Shuang Ho Hospital

    New Taipei City, 235, Taiwan

  • Teikyo University Hospital

    tabashi City, 173-8606, Japan

  • The First Affiliated Hospital of Sun Yat-Sen University

    Guangzhou, 510080, China

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, 710004, China

  • Tri-Service General Hospital

    Taipei, 114202, Taiwan

  • Universitaetsklinikum Muenster

    Münster, 48149, Germany

  • University of California Los Angeles - Division of Dermatology

    Los Angeles, California, 90024, United States

  • West China Hospital of Sichuan University

    Chengdu, 610041, China

  • Wuxi People s Hospital

    Wuxi, 214100, China

  • XLR8 Medical Research

    Windsor, Ontario, N8T 1E6, Canada

  • Xiangya Hospital Central South University

    Changsha, 410008, China

  • York Dermatology Clinic and Research Centre

    Richmond Hill, Ontario, L4B1L1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.